10.25384/SAGE.7982162.v1
Sandra Vukusic
Sandra
Vukusic
Patricia K Coyle
Patricia K
Coyle
Stephanie Jurgensen
Stephanie
Jurgensen
Philippe Truffinet
Philippe
Truffinet
Myriam Benamor
Myriam
Benamor
Salman Afsar
Salman
Afsar
Annie Purvis
Annie
Purvis
Elizabeth M Poole
Elizabeth M
Poole
Christina Chambers
Christina
Chambers
MSJ843055_supplemental_material – Supplemental material for Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience
SAGE Journals
2019
Multiple sclerosis
pregnancy
safety
teriflunomide
clinical study
post-marketing
2019-04-10 12:00:00
Journal contribution
https://sage.figshare.com/articles/journal_contribution/MSJ843055_supplemental_material_Supplemental_material_for_Pregnancy_outcomes_in_patients_with_multiple_sclerosis_treated_with_teriflunomide_Clinical_study_data_and_5_years_of_post-marketing_experience/7982162
<p>Supplemental material, MSJ843055_supplemental_material for Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience by Sandra Vukusic, Patricia K Coyle, Stephanie Jurgensen, Philippe Truffinet, Myriam Benamor, Salman Afsar, Annie Purvis, Elizabeth M Poole and Christina Chambers in Multiple Sclerosis Journal</p>